Effects of transforming growth factor alpha (TGF-alpha) on DNA synthesis and thyrotropin-induced iodine metabolism in cultured porcine thyroid cells. 1995

M Arai, and T Tsushima, and O Isozaki, and H Demura, and K Shizume, and N Emoto, and M Miyakawa, and Y Nozoe, and H Murakami, and E Ohmura
Institute for Growth Science, Tokyo, Japan.

Transforming growth factor alpha (TGF-alpha) is a potent mitogen that is similar structurally to epidermal growth factor (EGF). As EGF is a potent growth stimulator and an inhibitor of iodine metabolism in cultured thyroid cells of several species, we studied whether TGF-alpha has similar effects using porcine thyroid cells in culture. Recombinant human TGF-alpha dose-dependently stimulated DNA synthesis of thyroid cells, with maximal stimulation (eight- to ninefold above basal) occurring at 2 nmol/l. The potency was approximately 50% that of mouse EGF and correlated with the ability to compete with EGF for receptor binding, suggesting that the action of TGF-alpha is mediated by interaction with EGF receptors. When thyroid cells were cultured for 3 days with thyrotropin (TSH) in the presence of TGF-alpha, TSH-induced iodide uptake was inhibited in a dose-dependent manner. The potency of TGF-alpha again was approximately 50% that of EGF. Transforming growth factor alpha did not inhibit TSH-stimulated cAMP production. Moreover, iodide uptake stimulated by either forskolin or 8-bromo-cAMP also was inhibited by TGF-alpha. Thus, we conclude that TGF-alpha inhibits TSH-induced iodine metabolism largely by acting at the steps distal to cAMP production. Northern blot analysis revealed expression of TGF-alpha mRNA in porcine thyroid cells. These observations suggest that TGF-alpha acts as an autocrine modulator of growth and differentiated functions in porcine thyroid cells.

UI MeSH Term Description Entries
D007455 Iodine A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically. Iodine-127,Iodine 127
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004261 DNA Replication The process by which a DNA molecule is duplicated. Autonomous Replication,Replication, Autonomous,Autonomous Replications,DNA Replications,Replication, DNA,Replications, Autonomous,Replications, DNA
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

M Arai, and T Tsushima, and O Isozaki, and H Demura, and K Shizume, and N Emoto, and M Miyakawa, and Y Nozoe, and H Murakami, and E Ohmura
June 1992, The Journal of surgical research,
M Arai, and T Tsushima, and O Isozaki, and H Demura, and K Shizume, and N Emoto, and M Miyakawa, and Y Nozoe, and H Murakami, and E Ohmura
January 1986, In vitro cellular & developmental biology : journal of the Tissue Culture Association,
M Arai, and T Tsushima, and O Isozaki, and H Demura, and K Shizume, and N Emoto, and M Miyakawa, and Y Nozoe, and H Murakami, and E Ohmura
March 1982, Biochimica et biophysica acta,
M Arai, and T Tsushima, and O Isozaki, and H Demura, and K Shizume, and N Emoto, and M Miyakawa, and Y Nozoe, and H Murakami, and E Ohmura
October 1985, European journal of biochemistry,
M Arai, and T Tsushima, and O Isozaki, and H Demura, and K Shizume, and N Emoto, and M Miyakawa, and Y Nozoe, and H Murakami, and E Ohmura
March 1978, Endocrinology,
M Arai, and T Tsushima, and O Isozaki, and H Demura, and K Shizume, and N Emoto, and M Miyakawa, and Y Nozoe, and H Murakami, and E Ohmura
February 1978, Biochimica et biophysica acta,
M Arai, and T Tsushima, and O Isozaki, and H Demura, and K Shizume, and N Emoto, and M Miyakawa, and Y Nozoe, and H Murakami, and E Ohmura
December 1992, Journal of molecular endocrinology,
M Arai, and T Tsushima, and O Isozaki, and H Demura, and K Shizume, and N Emoto, and M Miyakawa, and Y Nozoe, and H Murakami, and E Ohmura
July 2018, Molecular and cellular endocrinology,
M Arai, and T Tsushima, and O Isozaki, and H Demura, and K Shizume, and N Emoto, and M Miyakawa, and Y Nozoe, and H Murakami, and E Ohmura
December 1986, Nihon Naibunpi Gakkai zasshi,
M Arai, and T Tsushima, and O Isozaki, and H Demura, and K Shizume, and N Emoto, and M Miyakawa, and Y Nozoe, and H Murakami, and E Ohmura
May 1999, Journal of cell science,
Copied contents to your clipboard!